Skip to Content

M 58 25 (Thioridazine 25 mg)

Pill imprint M 58 25 has been identified as Thioridazine hydrochloride 25 mg.

Thioridazine is used in the treatment of schizophrenia and belongs to the drug class phenothiazine antipsychotics. FDA has not classified the drug for risk during pregnancy. Thioridazine 25 mg is not a controlled substance under the Controlled Substance Act (CSA).

Thioridazine hydrochloride 25 mg M 58 25
Thioridazine hydrochloride 25 mg M 58 25
Thioridazine hydrochloride 25 mg M 58 25
Thioridazine hydrochloride 25 mg M 58 25 Front
Thioridazine hydrochloride 25 mg M 58 25 Back
Thioridazine hydrochloride
M 58 25
25 mg
7.00 mm
Prescription only
Drug Class:
Phenothiazine antipsychotics
Pregnancy Category:
N - Not classified
CSA Schedule:
Not a controlled drug
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
Inactive Ingredients:
silicon dioxide
croscarmellose sodium
FD&C Yellow No. 6
hydroxypropyl cellulose (type h)
magnesium stearate
microcrystalline cellulose
polyethylene glycol
sodium lauryl sulfate
titanium dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
51079-0566 UDL Laboratories Inc
54868-0067 Physicians Total Care Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.